Loeb Says Amgen Has Multiple Personalities, Should Be Broken Up; Company 'Appreciates' InputMark Melin
Daniel Loeb's hedge fund, Third Point LLC, might think its latest investment, Amgen, Inc. (NASDAQ:AMGN), has a multiple investment personality disorder.
Loeb divides Amgen into two distinct companies
In a letter to investors Loeb recommended the company be divided into two distinct companies: one a fast growing growth company, well suited for the active, momentum traders; and a second company, the mature growth company, that delivered solid dividends to shareholders.
If you are subscribed and having an account error please clear cache and cookies if that does not work email email@example.com or click chat